Susan Skrypack
Family · Valhalla, NYNPI 1073791380
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $853 and has fallen 59.3% since, to $348 in 2025. Among family clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 149 payments — averaging $22.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$633
- Amneal Pharmaceuticals LLC$414
- AbbVie$369
- Amgen$277
- Novo Nordisk$236
- Abbott$231
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,21298%
- Education$732%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 24 | $633 |
| Amneal Pharmaceuticals LLC | 18 | $414 |
| AbbVie | 15 | $369 |
| Amgen(2 entities) | 12 | $277 |
| Novo Nordisk | 8 | $236 |
| Abbott | 12 | $231 |
| Amarin Pharma, Inc. | 6 | $127 |
| Bayer | 6 | $120 |
| Clarus Therapeutics Inc. | 10 | $118 |
| Astellas Pharma US Inc | 3 | $105 |
| Alfasigma USA, Inc. | 6 | $98 |
| AstraZeneca | 5 | $93 |
| Xeris Pharmaceuticals, Inc. | 3 | $70 |
| Recordati_rare_diseases_inc. | 3 | $65 |
| Esperion Therapeutics, Inc. | 3 | $52 |
| EUSA Pharma (US) LLC | 2 | $43 |
| IBSA Pharma Inc. | 2 | $39 |
| Zealand Pharma US, Inc. | 2 | $35 |
| Lifescan, Inc. | 1 | $25 |
| Mannkind Corporation | 1 | $23 |
| Medtronic | 1 | $22 |
| Acerus Pharmaceuticals Corporation | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Verity Pharmaceuticals Inc. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $13 |
| Cequr Corporation | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,284 in reported general payments places this provider in the 90th percentile of 8,883 family providers in New York.
Other family in Valhalla
- Koulako CamaraValhalla$22K
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
- Sarah AljahmiRockville Centre$87K
- John de OcaStaten Island$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.